Advances in the study of biological agents in the treatment of Crohn’s disease
Crohn’s disease (CD) is a chronic, non-specific intestinal inflammatory disease. A large number of clinical trials have shown that biological agents are effective in inducing remission in patients with CD, and mainte-nance treatment can achieve long-term remission. At present, biological agents are...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of New Medicine
2021-12-01
|
| Series: | Yixue xinzhi zazhi |
| Subjects: | |
| Online Access: | https://yxxz.whuznhmedj.com/storage/attach/2112/ny0owt4kQPZ1HaXCp2UAV0bENdsAtmQZ4Np82O9Y.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850098754041937920 |
|---|---|
| author | Han-Han ZHENG Xue-Liang JIANG |
| author_facet | Han-Han ZHENG Xue-Liang JIANG |
| author_sort | Han-Han ZHENG |
| collection | DOAJ |
| description | Crohn’s disease (CD) is a chronic, non-specific intestinal inflammatory disease. A large number of clinical trials have shown that biological agents are effective in inducing remission in patients with CD, and mainte-nance treatment can achieve long-term remission. At present, biological agents are now being widely used in the treatment of CD and have become the main treatment. These include the anti-tumor necrosis factor (TNF)-α monoclo-nal antibodies, anti-integrin antibody, IL-12/23 monoclonal antibody and a Janus kinase (JAK) inhibitor. In this article, we review the progress and selection of biologics in the treatment of CD. |
| format | Article |
| id | doaj-art-be0dd14e778644afa9532e4470d7fea5 |
| institution | DOAJ |
| issn | 1004-5511 |
| language | zho |
| publishDate | 2021-12-01 |
| publisher | Editorial Office of New Medicine |
| record_format | Article |
| series | Yixue xinzhi zazhi |
| spelling | doaj-art-be0dd14e778644afa9532e4470d7fea52025-08-20T02:40:39ZzhoEditorial Office of New MedicineYixue xinzhi zazhi1004-55112021-12-0131644745410.12173/j.issn.1004-5511.2020110546267Advances in the study of biological agents in the treatment of Crohn’s diseaseHan-Han ZHENGXue-Liang JIANGCrohn’s disease (CD) is a chronic, non-specific intestinal inflammatory disease. A large number of clinical trials have shown that biological agents are effective in inducing remission in patients with CD, and mainte-nance treatment can achieve long-term remission. At present, biological agents are now being widely used in the treatment of CD and have become the main treatment. These include the anti-tumor necrosis factor (TNF)-α monoclo-nal antibodies, anti-integrin antibody, IL-12/23 monoclonal antibody and a Janus kinase (JAK) inhibitor. In this article, we review the progress and selection of biologics in the treatment of CD.https://yxxz.whuznhmedj.com/storage/attach/2112/ny0owt4kQPZ1HaXCp2UAV0bENdsAtmQZ4Np82O9Y.pdfcrohn’s disease biological agents treatment |
| spellingShingle | Han-Han ZHENG Xue-Liang JIANG Advances in the study of biological agents in the treatment of Crohn’s disease Yixue xinzhi zazhi crohn’s disease biological agents treatment |
| title | Advances in the study of biological agents in the treatment of Crohn’s disease |
| title_full | Advances in the study of biological agents in the treatment of Crohn’s disease |
| title_fullStr | Advances in the study of biological agents in the treatment of Crohn’s disease |
| title_full_unstemmed | Advances in the study of biological agents in the treatment of Crohn’s disease |
| title_short | Advances in the study of biological agents in the treatment of Crohn’s disease |
| title_sort | advances in the study of biological agents in the treatment of crohn s disease |
| topic | crohn’s disease biological agents treatment |
| url | https://yxxz.whuznhmedj.com/storage/attach/2112/ny0owt4kQPZ1HaXCp2UAV0bENdsAtmQZ4Np82O9Y.pdf |
| work_keys_str_mv | AT hanhanzheng advancesinthestudyofbiologicalagentsinthetreatmentofcrohnsdisease AT xueliangjiang advancesinthestudyofbiologicalagentsinthetreatmentofcrohnsdisease |